Location: Home
  • search
  • go
  • Relate News
  • 11/7/2008SFDA hosts forum on national essential drugs and relevant issues
  • 11/7/2008SFDA forms legal advisory panel
  • 11/7/2008SFDA cracks down on Wangdashan Pharma for serious violations that caus...
  • 11/7/2008Novo Nordisk announces major investment into Tianjin facility
  • 11/7/2008India initiates anti-dumping investigation against Chinese pencillin G...
  • 11/7/2008New Report: China to become the 4th largest Western drug market by 201...
  • 11/7/2008Wuxi PharmaTech gets new three-year deal from Pfizer
  • 11/7/2008Sanofi-Aventis, Pfizer discontinue obesity drug trials
  • 11/6/2008ImClone Systems gets antitrust approval to merge with Eli Lilly
  • 11/5/2008Novartis seeks to accelerate growth in China
  • 11/5/2008Hurun Report's 2008 China Pharma Rich List Released
  • 11/5/2008China Construction Bank to launch CNY 5 billion health fund
  • 11/5/2008SciClone's hepatitis C drug Zadaxin fails late-stage trial
  • 11/5/2008Is China Too Expensive?
  • 11/5/2008GlaxoSmithKline to cut US sales force by 1,000
  • 11/4/2008MOH and MOHRSS dispute over China's essential drug model
  • 11/4/2008SFDA tests water with third party validation in new drug registration ...
  • 11/4/2008Legend confirms internal transfer of its stake in Shijiazhuang Pharma ...
  • 11/4/2008Sidley Austin adds new senior life science councel in Shanghai
  • 11/4/2008Upcoming event: ACCESS India & China
  • 11/3/2008Government under mounting pressure to revise healthcare reform plan co...
  • 11/3/2008Is China ready for patent term restoration?
  • 11/3/2008China likely to raise quality standards of TCM injections amid rising ...
  • 11/3/2008Tianyao denies Pfizer acquisition rumor
  • 11/3/2008Roche announces expansion in China
  • 11/3/2008New report predicts double digit growth for China's OTC sector
  • 11/3/2008NeoStem to acquire China Biopharmaceuticals Holdings
  • 11/2/2008Hainan issues local healthcare reform policy
  • 11/2/2008Biogen Idec team up with Genentech in a deal to co-develop cancer drug...
  • 11/2/2008Wyeth joins wave of big pharma R&D restructuring
  • Page:627/719 Total number of articles:21546: [First][<<] [625] [626] [627] [628] [629] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group